跳至主要内容
临床试验/NCT03017859
NCT03017859Unknown不适用

High Flow Nasal Cannula as a Treatment for Obstructive Sleep Apnea

Rabin Medical Center0 个研究点目标入组 30 人开始时间: 2017年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
主要终点
Apnea Hypopnea Index (AHI)

研究概览

简要总结

A single center, prospective study to assess the efficacy of high flow nasal cannula (HFNC) in improving obstructive sleep apnea (OSA) parameters in patients with reduced tolerance to continuous positive airway pressure (CPAP) treatment.

详细描述

A single center, prospective study. The study would include 30 patients diagnosed within the past 2 years with moderate to severe OSA (AHI>=15) at the Rabin Medical Center (RMC) sleep lab, and who are intolerant to CPAP treatment. Following signing an informed consent form, these patients would undergo polysomnography (PSG) while treated with HFNC. The HFNC PSG outcome measures will be compared to the baseline PSG done within the past 2 years and to an additional PSG while connected to a CPAP device.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-80 years
  • Confirmed diagnosis of obstructive sleep apnea, diagnosed at RMC sleep lab in the past 2 years
  • Apnea Hypopnea Index (AHI)≥15
  • Patient has difficulties to adjust or comply with CPAP treatment
  • Signed Informed Consent Form

排除标准

  • Patients who need bilevel positive airway pressure (BIPAP)
  • Known carbon dioxide (CO2) retainers
  • Weight change>10% compared to time of OSA diagnosis
  • Clinically unstable patients
  • Pregnant women or special populations (e.g. children or patients unable to give informed consent)

结局指标

主要结局

Apnea Hypopnea Index (AHI)

时间窗: During at least 2 hours of sleep time

Comparison of HFNC AHI to baseline AHI and to CPAP AHI

次要结局

  • Minimal SO2%(During at least 2 hours of sleep time)
  • Percent of hypoxemia time(During at least 2 hours of sleep time)
  • Sleep efficiency(During at least 2 hours of sleep time)
  • Adverse events reported while using HFNC(During at least 2 hours of sleep time)
  • Total sleep time(During at least 2 hours of sleep time)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mordechai Kremer

Head of Pulmonary Institute

Rabin Medical Center

相似试验